Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Image Index

View All
Additional Pharmacology Considerations for Cancer Drug Marketing Applications
A Description of Current Immunotherapeutic Approaches in Myeloma
Anaplastic Lymphoma Kinase (ALK) Fusion
An Example of an Antibody-drug Conjugate (Ado-Trastuzumab Emtansine) in Action
Antifolate Mechanism of Action
Anti-Pd-1 and Anti-Pd-L1 Immunotherapies Have Demonstrated Unprecedented Clinical Activity
Aromatase Inhibitors (AIs)
Asparaginases, as Amidohydrolases, Possess Both Asparaginase and Glutaminase Activity
Available Antibody-drug Conjugates
Basic and Translation Approach to Clinical Trials
B-Cell Receptor (BCR)-ABL Translocation and the Philadelphia Chromosome
Biomarkers in Clinical Trials
Biosynthesis of and rogens and Other Steroid Hormones from Cholesterol
CDK4/CDK6 and mTOR Signaling Pathways
Cell Cycle and Temporarily Related Chromosome Cycle
Cellular (Nuclear and Nonnuclear Mechanisms of Estrogen Action)
Characterization and Selection of Biomarkers
Chemical Structure of Steroidal and Nonsteroidal Antiand rogens
Chemical Structures of Abiraterone and its Prodrug, Abiraterone Acetate
Chimeric Antigen Receptor (CAR) T-Cell Therapy and Bispecific Antibodies
Chromatin Structure and Epigenetic Marks
Clinical Drug Development Triad
Clinical Importance of Methylguanine Methyltransferase
Clinical Trial Facts
Clinical Trials Life Cycle
Comparison of the Molecular Pharmacological Audit Trial (MoPhAT) to the Pharmacological Audit Trial (PhAT)
Components of 90y-Ibritumomab Tiuxetan
Cyclophosphamide and Ifosfamide
Cytokine Toxicity Man
Design of Early-Phase Clinical Trials